[Federal Register Volume 72, Number 74 (Wednesday, April 18, 2007)]
[Notices]
[Pages 19521-19522]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E7-7331]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel: Adopting and Demonstrating the Adaptation of Prevention 
Techniques for Persons at Highest Risk of Acquiring or Transmitting 
Human Immunodeficiency Virus (ADAPT2), Funding Opportunity Announcement 
(FOA) Number PS07-004

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces a meeting of the aforementioned Special 
Emphasis Panel.
    Time and Date:
     8:30 a.m.-9 a.m., May 18, 2007 (Open).
     9 a.m.-4 p.m., May 18, 2007 (Closed).
    Place: Sheraton Midtown Atlanta Hotel at Colony Square, 188 14th 
Street, Atlanta, GA 30361.
    Status: The meeting will be closed to the public in accordance with 
provisions set forth in section 552b(c)(4) and (6), Title 5 U.S.C., and 
the Determination of the Director, Management Analysis and Services 
Office, CDC, pursuant to Public Law 92-463.
    Matters to be Discussed: The meeting will include the review, 
discussion, and evaluation of a research application in response to FOA 
PS07-004, ``Adopting and Demonstrating the Adaptation of Prevention 
Techniques for Persons at Highest Risk of Acquiring or Transmitting 
Human Immunodeficiency Virus (ADAPT2).''
    Contact Person For More Information: J. Felix Rogers, M.P.H., PhD, 
Scientific Review Administrator, Extramural Research Program Office, 
Centers for Disease Control and Prevention, 1600 Clifton Road, NE., MS 
E05, Atlanta, GA 30333, telephone 404.639.6101.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both CDC and the Agency for Toxic Substances and Disease Registry.


[[Page 19522]]


    Dated: April 10, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
 [FR Doc. E7-7331 Filed 4-13-07; 10:39 am]
BILLING CODE 4163-18-P